Ibex Medical Analytics
Pathology & Laboratory Diagnostics
Ibex Medical Analytics develops AI-powered cancer diagnostics for pathology labs, improving accuracy and efficiency in cancer detection.
About Ibex Medical Analytics
Ibex Medical Analytics provides AI-powered diagnostic solutions that help pathologists ensure better cancer care for patients around the world.
Leadership Team
Key executives and founders sourced from public LinkedIn profiles.
Ibex transforms cancer diagnosis. We use AI to help pathologists and providers improve diagnostic accuracy, efficiency and health economics. Our world class team of researchers, engineers and medical experts is growing. If you are an outstanding professional, passionate about your work, a team player and want to feel that you are making a difference - come join us. You’ll get the opportunity to work on challenging real-world problems, and help fight cancer while doing it! https://www.ibex-ai.com/jobs
Pioneering Artificial Intelligence in Pathology at Ibex, helping to improve cancer diagnostics and patient care. Entrepreneur and investor, driven by the ability to dramatically impact peoples lives. Founder of Kashya, a data security company acquired by Dell/EMC in 2006.
Mission & Approach
Mission
“We set out to transform pathology by ensuring that every patient can receive an accurate, timely and personalized cancer diagnosis.”
AI Approach
Computer vision, deep learning, machine learning for digital pathology image analysis
Founding Story
Founded in 2016 by Joseph Mossel and Chaim Linhart, PhD (CTO). The company was established to transform pathology through AI-powered diagnostics, with the goal of ensuring every patient receives accurate, timely, and personalized cancer diagnosis.
Products & Solutions
Ibex Prostate
softwareAI-powered prostate cancer detection with Gleason grading and feature analysis
AI solution for diagnosing prostatic cores with capabilities for cancer detection, Gleason grading, tumor sizing and detection of perineural invasion. Validated with area under the curve close to near perfect performance. Includes Ibex First Read for prostate workflow.
Ibex Breast Suite
softwareAI-powered breast cancer detection and diagnostic feature analysis
AI solution for detecting breast cancer and providing accurate insights on the type of invasive carcinomas, nuclear grading of in situ carcinomas and other diagnostic features. Validated to show near perfect concordance with consensus diagnosis between pathologists.
Ibex Breast HER2
softwareAI-powered HER2 analysis for breast cancer diagnostics
Specialized AI solution for HER2 biomarker analysis in breast cancer cases, part of the Ibex Breast Suite for comprehensive breast cancer diagnostics.
Ibex Biopharma
platformClinical-grade AI platform for drug development and biomarker analysis
Expansion of Ibex's clinical-grade AI platform into early translational research and biomarker development to accelerate drug development pipelines and enhance trial efficiency. Builds upon existing work in late-stage biomarker development for pharmaceutical applications.
Ibex Gastric
softwareAI-powered gastric cancer detection and grading solution
AI solution for detecting and grading gastric cancer with automated high-quality insights that enhance patient safety and increase physician confidence in gastric pathology workflows.
Ibex Platform
FlagshipplatformAI-powered multi-tissue pathology platform for cancer detection and grading
Clinical-grade, multi-tissue AI platform that helps pathologists detect and grade breast, prostate and gastric cancer, along with more than a hundred other clinically relevant features. Developed from over 10 million slides, the platform seamlessly integrates with third party digital pathology software solutions, scanning platforms and laboratory information systems to deliver automated high-quality insights.
Customer Success Stories
University of Pittsburgh Medical Center (UPMC)
health system
Validation study of Ibex Prostate solution for cancer diagnosis, Gleason grading, tumor sizing and perineural invasion detection
Brigham and Women's Hospital
hospital
Implementation of Ibex Breast to transform pathologists' work through accuracy and broad detection capabilities
The University of Tennessee Health Science Center
hospital
Detection of small foci of cancer and higher-grade cancers, providing additional prospective quality control
Betsi Cadwaladr University Health Board, Wales
health system
AI-assisted diagnosis of prostatic cores for correct and reproducible tissue diagnosis across pathology team
Institut Curie, Paris
hospital
Validation of Ibex Breast for cancer diagnosis, invasive carcinoma typing, and nuclear grading of in situ carcinomas
Hiring Activity
View Open Roles →Product & Market
Product Stage
enterprisePrimary Market
providersCompany Details
- Founded
- 2016
- Headquarters
- Tel Aviv, Israel
- Employees
- 150
- Stage
- series c
- Profile last updated
- June 22, 2026
Official Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSocial & Media
Follow on
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.